Consolidated Statement of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues
Revenues	$ 416	$ 239
Expenses
Research and development expense	860	797
Selling, general and administrative expense	1,704	1,280
Depreciation of tangible assets	171	183
Total expenses	2,735	2,260
Operating loss	(2,319)	(2,021)
Interest income	29
Financing and interest expense	(298)	(243)
Net financing and interest expense	(269)	(243)
Net Loss	(2,588)	(2,264)
Other Comprehensive Income (Loss)
Foreign currency translation adjustment	223	(72)
Change in fair value	24	(5)
Total other comprehensive income (loss)	247	(77)
Comprehensive loss	$ (2,341)	$ (2,341)
Basic and Diluted Weighted Average Number of Shares Outstanding (in shares)	93,519,140	67,404,467
Basic and Diluted Loss Per Common Share (in dollars per share)	$ (0.03)	$ (0.03)